Tempest Therapeutics (TPST) Restructuring Costs (2016 - 2018)

Tempest Therapeutics has disclosed Restructuring Costs across 3 years of filings, most recently posting $121000.0 for Q4 2018.

• In Q4 2018, Restructuring Costs fell 35.64% year-over-year to $121000.0; the TTM figure through Dec 2018 stood at $3.8 million (down 7.41% YoY), while the FY2018 annual figure was $3.8 million, down 6.75% from the prior year.
• Restructuring Costs came in at $121000.0 for Q4 2018 at Tempest Therapeutics, up from $53000.0 in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $5.4 million in Q4 2016 to a low of $53000.0 in Q3 2018.
• Average Restructuring Costs over 3 years is $1.5 million, with a median of $700000.0 recorded in 2018.
• Year-over-year, Restructuring Costs slumped 96.52% in 2017 and soared 45.0% in 2018.
• Over 3 years, Restructuring Costs stood at $5.4 million in 2016, then tumbled by 96.52% to $188000.0 in 2017, then sank by 35.64% to $121000.0 in 2018.
• Per Business Quant data, the three most recent Restructuring Costs figures were $121000.0 in Q4 2018, $53000.0 in Q3 2018, and $2.9 million in Q2 2018.